Molecular Partners Ag MOLN
NASDAQ MOLN
$3.10 -0.04 (-1.27%)
At close: Nov 9, 2026 · 4:00 PM EST

Molecular Partners Ag (MOLN) Price to Sales (2022 - 2026)

Updated

Molecular Partners Ag's (MOLN) Price to Sales stood at 198.79 in Q2 2026, up 222.5% from 61.65 a year earlier.

Analysis

Molecular Partners Ag (MOLN) Price to Sales (2022 - 2026) Analysis & Trends

For FY2024, Molecular Partners Ag's Price to Sales came in at 33.94, up 75.0% from FY2023.

  • Across earlier years, Price to Sales came in at 19.39 in FY2023, 1.19 in FY2022 (-98.0%) and 58.02 in FY2021.
  • The Q2 2026 figure is the highest quarterly Price to Sales in data going back to Q2 2021.
  • Peak year-over-year performance for Price to Sales in the last five years was growth of 222.5% in Q2 2026, against a decline of 98.8% in Q2 2022 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Molecular Partners Ag 125.16 Mn -243.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 198.79
Jun 30, 2025 61.65
Dec 31, 2024 34.01
Sep 30, 2024 27.21
Jun 30, 2024 29.56
Mar 31, 2024 19.99
Dec 31, 2023 19.48
Sep 30, 2023 15.82
Jun 30, 2023 24.90
Mar 31, 2023 10.49
Dec 31, 2022 1.15
API Access

Molecular Partners Ag Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=MOLN&period=max&api_key=YOUR_API_KEY